APP and early-onset autosomal dominant Alzheimer disease: 5-HT4Rs are also implicated in Alzheimer’s disease, where they play a role in interacting with the alpha-secretase ADAM10, promoting non-amyloidogenic cleavage of the amyloid precursor protein and thus preventing pathological amyloid plaque formation [34].